Articles Tagged with recall

Published on:

asbestos in crayons - Dallas, TX - Reyes Browne ReilleyThe US Public Interest Research Group Education Fund has found asbestos in crayons. The agency conducted tests on six brands of crayons sold at Dollar Tree. Five of the six brands passed, with the exception of Playskool. Dangerous amounts of Tremoline were detected inside of their green crayon. Tremoline is a type of Asbestos, and exposure to this harmful chemical can cause life threatening complications such as lung cancer, mesothelioma, and others.

The US PIRG has asked retailers of Playskool crayons to stop selling them immediately remove them from their inventory. This affected retailers such as Dollar Tree, Amazon, eBay, and

“We are conducting a thorough investigation into these claims, including working with Leap Year, the licensee of the product,” Katy Hendrickson Director, Hasbro’s director of global communications said.

Published on:

shutterstock_98508260-300x200If this post doesn’t spell out how truly incompetent the Food and Drug Administration is, nothing will. Last week, the FDA recalled the 300mg generic version of Wellbutrin XL. Why? Because it simply doesn’t work. What’s worse (but not surprising) is that the problem with this drug has been around for several years but the FDA chose to ignore it.

As is the case with many other generic drugs, the FDA approved this one with no testing whatsoever. The generic version of Wellbutrin XL comes in 150mg and 300mg doses. Apparently the 150mg dose works just fine. So keeping in line with their lackadaisical attitude toward consumer safety, the FDA made the assumption that if one dose works, the other obviously will too. The 300mg dose is prescribed for patients who have severe depression and anxiety. It was released on the market in 2006. Shortly thereafter, the FDA began receiving numerous complaints from patients.

The FDA is supposed to approve drugs based on its own studies. Instead, it often relies on manufacturers for this task. In this particular instance, Teva, the marketer of the drug which is manufactured by Impax Laboratories, was instructed to do the trial and didn’t, claiming “slow patient enrollment” as the reason. So in 2010, four years after approving the generic, the FDA did its own study which was completed last year. The study concluded that the 300mg dose of the generic version of Wellbutrin XL is ineffective because it doesn’t deliver enough of the drug.

Contact Information